Interactions of complement proteins C1q and factor H with lipid A and Escherichia coli: further evidence that factor H regulates the classical complement pathway

Abstract

Proteins of the complement system are known to interact with many charged substances. We recently characterized binding of C1q and factor H to immobilized and liposomal anionic phospholipids. Factor H inhibited C1q binding to anionic phospholipids, suggesting a role for factor H in regulating activation of the complement classical pathway by anionic phospholipids. To extend this finding, we examined interactions of C1q and factor H with lipid A, a well-characterized activator of the classical pathway. We report that C1q and factor H both bind to immobilized lipid A, lipid A liposomes and intact Escherichia coli TG1. Factor H competes with C1q for binding to these targets. Furthermore, increasing the factor H: C1q molar ratio in serum diminished C4b fixation, indicating that factor H diminishes classical pathway activation. The recombinant forms of the C-terminal, globular heads of C1q A, B and C chains bound to lipid A and E. coli in a manner qualitatively similar to native C1q, confirming that C1q interacts with these targets via its globular head region. These observations reinforce our proposal that factor H has an additional complement regulatory role of down-regulating classical pathway activation in response to certain targets. This is distinct from its role as an alternative pathway downregulator. We suggest that under physiological conditions, factor H may serve as a downregulator of bacterially-driven inflammatory responses, thereby fine-tuning and balancing the inflammatory response in infections with Gram-negative bacteria.

Keywords

complement / lipid A / bacteria / factor H / C1q

References

[1] Albertí, S., Marqués, G., Hernández-Allés, S., Rubires, X., Tomás, J.M., Vivanco, F., and Benedí, V.J. (1996). Interaction between complement subcomponent C1q and the Klebsiella pneumoniae porin OmpK36. Infect Immun 64, 4719–4725 .8890231
[2] Arvieux, J., Reboul, A., Bensa, J.C., and Colomb, M.G. (1984). Characterization of the C1q receptor on a human macrophage cell line, U937. Biochem J 218, 547–555 .6370241
[3] Bone, R.C. (1991). The pathogenesis of sepsis. Ann Intern Med 115, 457–469 .1872494
[4] Bunse, R., and Heinz, H.P. (1993). Interaction of the capsular polysaccharide of Haemophilus influenzae type B with C1q. Behring Inst Mitt 93, 148–164 .8172562
[5] Clas, F., Euteneuer, B., Stemmer, F., and Loos, M. (1989). Interaction of fluid phase C1/C1q and macrophage membrane-associated C1q with gram-negative bacteria. Behring Inst Mitt 84, 236–254 .2552981
[6] Charlesworth, J.A., Scott, D.M., Pussell, B.A., and Peters, D.K. (1979). Metabolism of human beta 1H: studies in man and experimental animals. Clin Exp Immunol 38, 397–404 .
[7] Cooper, N.R., and Morrison, D.C. (1978). Binding and activation of the first component of human complement by the lipid A region of lipopolysaccharides. J Immunol 120, 1862–1868 .351060
[8] Díaz, A., Ferreira, A., and Sim, R.B. (1997). Complement evasion by Echinococcus granulosus: sequestration of host factor H in the hydatid cyst wall. J Immunol 158, 3779–3786 .9103443
[9] Dillon, S.P., D’Souza, A., Kurien, B.T., and Scofield, R.H. (2009). Systemic lupus erythematosus and C1q: A quantitative ELISA for determining C1q levels in serum. Biotechnol J 4, 1210–1214 .19370710
[10] Dodds, A.W., Sim, R.B., Porter, R.R., and Kerr, M.A. (1978). Activation of the first component of human complement (C1) by antibody-antigen aggregates. Biochem J 175, 383–390 .743203
[11] Edey, M., Strain, L., Ward, R., Ahmed, S., Thomas, T., and Goodship. T.H. (2009). Is complement factor H a susceptibility factor for IgA nephropathy? Mol Immunol 46, 1405–1408 .
[12] Eisenschenk, F.C., Houle, J.J., and Hoffmann, E.M. (1999). Mechanism of serum resistance among Brucella abortus isolates. Vet Microbiol 68, 235–244 .10510042
[13] Fearon, D.T. (1978). Regulation by membrane sialic acid of 1H-dependent decay-dissociation of amplification C3 convertase of the alternative complement pathway. Proc Natl Acad Sci U S A 75, 1971–1975 .273923
[14] Gaboriaud, C., Juanhuix, J., Gruez, A., Lacroix, M., Darnault, C., Pignol, D., Verger, D., Fontecilla-Camps, J.C., and Arlaud, G.J. (2003). The crystal structure of the globular head of complement protein C1q provides a basis for its versatile recognition properties. J Biol Chem 278, 46974–46982 .12960167
[15] Gulati, S., Cox, A., Lewis, L.A., Michael, F.S., Li, J., Boden, R., Ram, S., and Rice, P.A. (2005). Enhanced factor H binding to sialylated Gonococci is restricted to the sialylated lacto-N-neotetraose lipooligosaccharide species: implications for serum resistance and evidence for a bifunctional lipooligosaccharide sialyltransferase in Gonococci. Infect Immun 73, 7390–7397 .16239538
[16] de Haas, C.J., van Leeuwen, E.M., van Bommel, T., Verhoef, J., van Kessel, K.P., and van Strijp, J.A. (2000). Serum amyloid P component bound to gram-negative bacteria prevents lipopolysaccharide-mediated classical pathway complement activation. Infect Immun 68, 1753–1759 .10722560
[17] Ingram, G., Hakobyan, S., Hirst, C.L., Harris, C.L., Pickersgill, T.P., Cossburn, M.D., Loveless, S., Robertson, N.P., and Morgan, B.P. (2010). Complement regulator factor H as a serum biomarker of multiple sclerosis disease state. Brain 133, 1602–1611 .
[18] Jack, D.L., and Turner, M.W. (2003). Anti-microbial activities of mannose-binding lectin. Biochem Soc Trans 31, 753–757 .12887297
[19] Joiner, K.A., Schmetz, M.A., Sanders, M.E., Murray, T.G., Hammer, C.H., Dourmashkin, R., and Frank, M.M. (1985). Multimeric complement component C9 is necessary for killing of Escherichia coli J5 by terminal attack complex C5b-9. Proc Natl Acad Sci U S A 82, 4808–4812 .3895225
[20] Joiner, K.A., Grossman, N., Schmetz, M., and Leive, L. (1986). C3 binds preferentially to long-chain lipopolysaccharide during alternative pathway activation by Salmonella montevideo. J Immunol 136, 710–715 .2416822
[21] Kishore, U., Gupta, S.K., Perdikoulis, M.V., Kojouharova, M.S., Urban, B.C., and Reid, K.B.M. (2003). Modular organization of the carboxyl-terminal, globular head region of human C1q A, B, and C chains. J Immunol 171, 812–820 .12847249
[22] Kishore, U., Ghai, R., Greenhough, T.J., Shrive, A.K., Bonifati, D.M., Gadjeva, M.G., Waters, P., Kojouharova, M.S., Chakraborty, T., and Agrawal, A. (2004a). Structural and functional anatomy of the globular domain of complement protein C1q. Immunol Lett 95, 113–128 .15388251
[23] Kishore, U., Gaboriaud, C., Waters, P., Shrive, A.K., Greenhough, T.J., Reid, K.B.M., Sim, R.B., and Arlaud, G.J. (2004b). C1q and tumor necrosis factor superfamily: modularity and versatility. Trends Immunol 25, 551–561 .15364058
[24] Kojouharova, M.S., Gadjeva, M.G., Tsacheva, I.G., Zlatarova, A., Roumenina, L.T., Tchorbadjieva, M.I., Atanasov, B.P., Waters, P., Urban, B.C., Sim, R.B., (2004). Mutational analyses of the recombinant globular regions of human C1q A, B, and C chains suggest an essential role for arginine and histidine residues in the C1q-IgG interaction. J Immunol 172, 4351–4358 .15034050
[25] Kraiczy, P., and Würzner, R. (2006). Complement escape of human pathogenic bacteria by acquisition of complement regulators. Mol Immunol 43, 31–44 .16011850
[26] Kubens, B.S., Nikolai, S., and Opferkuch, W. (1989). A third mechanism of serum resistance in Escherichia coli. Zentralbl Bakteriol 271, 222–230 .2528357
[27] Laemmli, U.K. (1970). Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227, 680–685 .5432063
[28] Latsch, M., Stemmer, F., and Loos, M. (1992). Purification and characterization of LPS-free porins isolated from Salmonella minnesota. FEMS Microbiol Lett 69, 275–281 .1372873
[29] Loos, M., and Clas, F. (1987). Antibody-independent killing of gram-negative bacteria via the classical pathway of complement. Immunol Lett 14, 203–208 .3032781
[30] Maruvada, R., Blom, A.M., and Prasadarao, N.V. (2008). Effects of complement regulators bound to Escherichia coli K1 and Group B Streptococcus on the interaction with host cells. Immunology 124, 265–276 .18028369
[31] McAleer, M.A., and Sim, R.B. (1993). The complement system. In: Activators and Inhibitors of Complement . Sim, R.B. ed. Dordrecht, Netherlands: Kluwer.1–15 .
[32] Meri, S., and Pangburn, M.K. (1990). Discrimination between activators and nonactivators of the alternative pathway of complement: regulation via a sialic acid/polyanion binding site on factor H. Proc Natl Acad Sci U S A 87, 3982–3986 .1692629
[33] Merino, S., Vilches, S., Canals, R., Ramirez, S., and Tomás, J.M. (2005). A C1q-binding 40 kDa porin from Aeromonas salmonicida: cloning, sequencing, role in serum susceptibility and fish immunoprotection. Microb Pathog 38, 227–237 .15885977
[34] Morrison, D.C., and Kline, L.F. (1977). Activation of the classical and properdin pathways of complement by bacterial lipopolysaccharides (LPS). J Immunol 118, 362–368 .318670
[35] New, R.C.C. (1990). Preparation of liposomes, In: Liposomes - a practical approach . New, R. C. C. (ed.). Oxford, U.K. IRL Press, 3–104 .
[36] Reid, K.B., and Porter, R.R. (1976). Subunit composition and structure of subcomponent C1q of the first component of human complement. Biochem J 155, 19–23 .938474
[37] Rietschel, E.T., Kirikae, T., Schade, F.U., Mamat, U., Schmidt, G., Loppnow, H., Ulmer, A.J., Z?hringer, U., Seydel, U., Di Padova, F., (1994). Bacterial endotoxin: molecular relationships of structure to activity and function. FASEB J 8, 217–225 .8119492
[38] Ripoche, J., Day, A.J., Harris, T.J., and Sim, R.B. (1988). The complete amino acid sequence of human complement factor H. Biochem J 249, 593–602 .2963625
[39] Roumenina, L.T., Rouseva, M., Zlatarova, A., Kolev, M., Ghai, R., Olova, N., Gadjeva, M., Agrawal, A., Mantovani, A., Bottazzi, B., (2006). Interaction of C1q with IgG1, C-reactive protein and pentraxin 3: mutational analyses using recombinant globular regions of C1q A, B and C chains. Biochemistry 45, 4093–4104 16566583.
[40] Schneider, M.C., Exley, R.M., Chan, H., Feavers, I., Kang, Y.H., Sim, R.B., and Tang, C.M. (2006). Functional significance of factor H binding to Neisseria meningitidis. J Immunol 176, 7566–7575 .16751403
[41] Shang, S.Q., Chen, G.X., Shen, J., Yu, X.H., and Wang, K.Y. (2005). The binding of MBL to common bacteria in infectious diseases of children. J Zhejiang Univ Sci B 6, 53–56 .15593393
[42] Sim, R.B., and Malhotra, R. (1994). Interactions of carbohydrates and lectins with complement. Biochem Soc Trans 22, 106–111 .8206200
[43] Sim, E., and Sim, R.B. (1983). Enzymic assay of C3b receptor on intact cells and solubilized cells. Biochem J 210, 567–576 .6222733
[44] Sim, R.B., Day, A.J., Moffatt, B.E., and Fontaine, M. (1993). Complement factor I and cofactors in control of complement system convertase enzymes. Methods Enzymol 223, 13–35 .8271948
[45] Stewart, J.C. (1980). Colorimetric determination of phospholipids with ammonium ferrothiocyanate. Anal Biochem 104, 10–14 .6892980
[46] Tan, L.A., Yu, B., Sim, F.C., Kishore, U., and Sim, R.B. (2010). Complement activation by phospholipids: the interplay of factor H and C1q. Protein Cell 1, 1033–1049 .21153520
[47] van den Berg, R.H., Faber-Krol, M.C., van de Klundert, J.A., van Es, L.A., and Daha, M.R. (1996). Inhibition of the hemolytic activity of the first component of complement C1 by an Escherichia coli C1q binding protein. J Immunol 156, 4466–4473 .8666822
[48] Weiler, J.M., Daha, M.R., Austen, K.F., and Fearon, D.T. (1976). Control of the amplification convertase of complement by the plasma protein 1H. Proc Natl Acad Sci U S A 73, 3268–3272 .1067618
[49] Whaley, K., and Ruddy, S. (1976). Modulation of the alternative complement pathways by 1 H globulin. J Exp Med 144, 1147–1163 .62817
[50] Ying, S.C., Gewurz, A.T., Jiang, H., and Gewurz, H. (1993). Human serum amyloid P component oligomers bind and activate the classical complement pathway via residues 14-26 and 76-92 of the A chain collagen-like region of C1q. J Immunol 150, 169–176 .8417122
[51] Zipfel, P.F., Würzner, R., and Skerka, C. (2007). Complement evasion of pathogens: common strategies are shared by diverse organisms. Mol Immunol 44, 3850–3857 .17768102
[52] Zohair, A., Chesne, S., Wade, R.H., and Colomb, M.G. (1989). Interaction between complement subcomponent C1q and bacterial lipopolysaccharides. Biochem J 257, 865–873 .2649081